![Jeff Baxter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Baxter
Verkställande Direktör på
VBI Vaccines (Delaware), Inc.
Profil
Jeffrey R.
Baxter is currently President, Chief Executive Officer & Director at VBI Vaccines (Delaware), Inc. since 2014.
Mr. Baxter is also President & Director at Variation Biotechnologies (US), Inc. Former positions include President, Chief Executive Officer & Director at VBI Vaccines, Inc. from 2016 to 2025; Independent Non-Executive Director at Niagen Bioscience, Inc. from 2015 to 2022; Principal at British American Tobacco plc; Principal at Unilever Plc; SVP-Research & Development Finance at GSK Plc from 2002 to 2006; and Managing Partner at The Column Group LLC.
Education includes undergraduate studies at the University of West London.
Aktiva positioner av Jeff Baxter
| Företag | Position | Start |
|---|---|---|
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | President | - |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Verkställande Direktör | 2014-07-01 |
Tidigare kända positioner av Jeff Baxter
| Företag | Position | Slut |
|---|---|---|
| VBI VACCINES INC. | Verkställande Direktör | 2025-01-03 |
| NIAGEN BIOSCIENCE, INC. | Direktör/Styrelseledamot | 2022-04-04 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Chef för investeringar | 2009-02-28 |
| GSK PLC | Företagsledare/Principal | 2006-07-01 |
| UNILEVER PLC | Företagsledare/Principal | - |
Jeff Baxters utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
57
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
British American Tobacco plc
 British American Tobacco plc TobaccoConsumer Non-Durables Manufactures and supplies tobacco products | Consumer Non-Durables |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
University of West London
 University of West London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
